Loading...
XNAS
WORX
Market cap1mUSD
Jun 02, Last price  
0.52USD
1D
-0.87%
1Q
-41.78%
Jan 2017
-85.13%
IPO
-72.05%
Name

Scworx Corp

Chart & Performance

D1W1MN
XNAS:WORX chart
No data to show
P/E
P/S
0.64
EPS
Div Yield, %
Shrs. gr., 5y
28.42%
Rev. gr., 5y
-11.63%
Revenues
3m
-21.43%
0591,4394,217,704150,0895,548,1195,213,1184,632,5294,038,1883,804,9432,989,599
Net income
-1m
L-71.46%
-386,456-4,159,394-11,978,563-14,592,246-11,479,876-7,402,350-3,814,468-1,568,215-3,981,144-1,136,225
CFO
-1m
L+34.50%
-2,018,144-5,570,642-3,578,445-4,691,290-959,070-1,069,945-546,663-806,164-1,084,292

Profile

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
IPO date
Oct 06, 2016
Employees
9
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,990
-21.43%
3,805
-5.78%
4,038
-12.83%
Cost of revenue
3,000
5,256
6,165
Unusual Expense (Income)
NOPBT
(10)
(1,451)
(2,127)
NOPBT Margin
Operating Taxes
(279)
Tax Rate
NOPAT
(10)
(1,451)
(1,847)
Net income
(1,136)
-71.46%
(3,981)
153.86%
(1,568)
-58.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
168
573
725
BB yield
Debt
Debt current
27
125
Long-term debt
20
90
148
Deferred revenue
Other long-term liabilities
(148)
Net debt
(60)
(1)
23
Cash flow
Cash from operating activities
(1,084)
(806)
(547)
CAPEX
Cash from investing activities
165
Cash from financing activities
1,100
483
725
FCF
(603)
(869)
(1,958)
Balance
Cash
107
91
249
Long term investments
Excess cash
48
Stockholders' equity
(30,974)
(29,839)
(25,246)
Invested Capital
35,511
33,782
32,295
ROIC
ROCE
EV
Common stock shares outstanding
1,459
1,033
798
Price
Market cap
EV
EBITDA
40
(1,451)
(2,127)
EV/EBITDA
Interest
104
6
279
Interest/NOPBT